MBX Biosciences, Inc. logo

MBX Biosciences, Inc.

MBX • XNAS

MBX Biosciences, Inc. is a pharmaceutical preparations company trading on XNAS, led by CEO Peter Kent Hawryluk, with a market cap of $1.6B.

Market Cap$1.6B
Employees38.0
CEOPeter Kent Hawryluk
CountryUnited States of America
PHARMACEUTICAL PREPARATIONS
Next EarningsMay 11, 2026 · In 4 weeksQ1 2026
Income StatementBalance SheetCash FlowBusiness Segments

Financials

View all metrics

Revenue

View metric

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric
MBX Biosciences, Inc. logo

MBX Biosciences, Inc. FAQ

Common questions about MBX Biosciences, Inc.

MBX Biosciences, Inc. is scheduled to report earnings for Q1 2026 on May 11, 2026.

MBX Biosciences, Inc. has approximately 38 employees.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.

MBX Biosciences, Inc. (MBX) Q1 2026 Earnings - OpenCapital